Page 18 - Read Online
P. 18

Page 4 of 7                                                   Freedman. Hepatoma Res 2020;6:10  I  http://dx.doi.org/10.20517/2394-5079.2019.32


























               Figure 1. Age distribution of subjects in the study. The Y-axis is the number of patients per age group and the X-axis the age groups


               Table 1. Baseline and outcome characteristics
                                                80+           %          70-80         %           P
                n                           32                        161
                Age [median (min-max)]      74.2 (70-79.6)            82.3 (80.1-86.3)
                Male                        21               66%      131             81%          0.08
                Associated liver disease    19               59%      129             80%          0.021
                Alcohol                     8                25%      63              39%          0.189
                Hemochromatosis             1                3%       5               3%           NS
                Hepatitis B                 0                0%       4               2%           NS
                Hepatitis C                 1                3%       34              21%          0.016
                NASH                        5                16%      25              16%          NS
                Porfyria                    1                3%       2               1%           NS
                Child-Pugh
                   A                        24               75%      114             71%          NS
                   B                        4                13%      18              11%          NS
                   C                        0                0%       0               0%           NS
                Missing                     4                13%      28              17%          NS
                MELD [median (min-max)]     6.58 (0.86-22.78)         6.26 (0-19.32)               NS
                ASA
                   1                       0                 0%       2               1%           NS
                   2                       7                 22%      39              24%          NS
                   3                       21                66%      93              58%          NS
                   4                       4                 13%      25              16%          NS
                Number of tumours
                   1                       20                63%      88              55%          NS
                   2                       6                 19%      34              21%          NS
                   3+                      6                 19%      36              22%          NS
                Max diameter [median (min-max)]  22 (11-37)           20 (8-58)                    NS
                Clavien-Dindo class
                   0-1                     28                84%      142             88%          NS
                   2                       4                 13%      12              7%           NS
                   3a                      0                 0%       5               3%           NS
                   3b                      0                 0%       1               1%           NS
                   4a                      0                 0%       1               1%           NS
                   4b                      0                 0%       0               0%           NS
                   5                       0                 0%       0               0%           NS
                Postop stay [median (min-max)]  1 (0-5)               1 (0-32)                     NS
                Number of subsequent liver treatments  1 (1-6)        2 (1-7)                      NS

               Baseline characteristics and complications following microwave ablation for hepatocellular carcinoma in elderly patients. Only
               associated liver disease reached statistical significance with a P-value < 0.05. NASH: Non Alcohol Steato Hepatitis; MELD: Model for
               Endstage Liver Disease; ASA: American Society of Anaesthetists physical status classification
   13   14   15   16   17   18   19   20   21   22   23